Artificial Intelligence (AI) in Drug Discovery Market 2020 Size, Share, Growth & Forecast to 2026
At 31.7% CAGR, Artificial Intelligence (AI) in Drug Discovery Market Size is Expected to Exhibit 2.01 billion USD by 2026, according to the analysis of MarketandReport.
Scope of the Report:
The detailed market intelligence report on the Global Artificial Intelligence(AI) in Drug Discovery Market Covers the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Artificial Intelligence in Drug Discovery Market place for the forecast 2019-2026.
Request for Sample Report @ https://www.marketandreport.com/sample_request?artificial-intelligence-in-drug-discovery-market-2393
Global Artificial Intelligence in Drug Discovery market research report provides detail information about Market Introduction, Market Summary, Global market Revenue, Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis and Regional Analysis.
The Major Players are covered:
IBM Corporation (US)
Microsoft (US)
Google (US)
NVIDIA Corporation (US)
Atomwise, Inc. (US)
Exscientia (UK)
Cyclica (Canada)
BIOAGE (US)
Numerate (US)
Numedii (US)
Envisagenics (US)
twoXAR (US),
OWKIN, Inc. (US)
XtalPi (US)
Verge Genomics (US)
Berg LLC (US)
Deep Genomics (Canada)
Cloud Pharmaceuticals (US)
Insilico Medicine (US)
Benevolent AI (UK)
…
IBM Corporation (US): IBM is among the leading companies in the AI in the drug discovery market. End-users widely use the company's Watson for cognitive computing and data-driven applications. IBM follows organic as well as inorganic growth strategies to improve its position in the AI in drug discovery and other emerging AI markets.
For Detailed Report >> https://www.marketandreport.com/report?artificial-intelligence-in-drug-discovery-market-2393
1 Executive Summary
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
2.4 Market Size Estimation
2.5 Forecast Model
3 Market Overview
3.1 Artificial Intelligence in Drug Discovery Introduction
3.2 Market Analysis by Type
3.3 Market Analysis by Applications
3.4 Market Analysis by Regions
3.5 Market Dynamics
4 Manufacturers Profiles
4.1 IBM Corporation (US)
4.2 Microsoft (US)
4.3 Google (US)
4.4 NVIDIA Corporation (US)
4.5 Atomwise, Inc. (US)
4.6 Exscientia (UK)
4.7 Cyclica (Canada)
4.8 BIOAGE (US)
4.9 Numerate (US)
4.10 Numedii (US)
4.11 Envisagenics (US)
4.12 twoXAR (US),
4.13 OWKIN, Inc. (US)
4.14 XtalPi (US)
4.15 Verge Genomics (US)
4.16 Berg LLC (US)
4.17 Deep Genomics (Canada)
4.18 Cloud Pharmaceuticals (US)
4.19 Insilico Medicine (US)
4.20 Benevolent AI (UK)
…
Buy Now: https://www.marketandreport.com/buy_now?artificial-intelligence-in-drug-discovery-market-2393
Contact Us:
Mike
Partner Relations & Marketing Manager
MarketandReport
400 Skokie Blvd, STE 200,
Northbrook, IL 60062, USA
Email: sales@marketandreport.com
Scope of the Report:
The detailed market intelligence report on the Global Artificial Intelligence(AI) in Drug Discovery Market Covers the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Artificial Intelligence in Drug Discovery Market place for the forecast 2019-2026.
Request for Sample Report @ https://www.marketandreport.com/sample_request?artificial-intelligence-in-drug-discovery-market-2393
Global Artificial Intelligence in Drug Discovery market research report provides detail information about Market Introduction, Market Summary, Global market Revenue, Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis and Regional Analysis.
The Major Players are covered:
IBM Corporation (US)
Microsoft (US)
Google (US)
NVIDIA Corporation (US)
Atomwise, Inc. (US)
Exscientia (UK)
Cyclica (Canada)
BIOAGE (US)
Numerate (US)
Numedii (US)
Envisagenics (US)
twoXAR (US),
OWKIN, Inc. (US)
XtalPi (US)
Verge Genomics (US)
Berg LLC (US)
Deep Genomics (Canada)
Cloud Pharmaceuticals (US)
Insilico Medicine (US)
Benevolent AI (UK)
…
IBM Corporation (US): IBM is among the leading companies in the AI in the drug discovery market. End-users widely use the company's Watson for cognitive computing and data-driven applications. IBM follows organic as well as inorganic growth strategies to improve its position in the AI in drug discovery and other emerging AI markets.
For Detailed Report >> https://www.marketandreport.com/report?artificial-intelligence-in-drug-discovery-market-2393
1 Executive Summary
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
2.4 Market Size Estimation
2.5 Forecast Model
3 Market Overview
3.1 Artificial Intelligence in Drug Discovery Introduction
3.2 Market Analysis by Type
3.3 Market Analysis by Applications
3.4 Market Analysis by Regions
3.5 Market Dynamics
4 Manufacturers Profiles
4.1 IBM Corporation (US)
4.2 Microsoft (US)
4.3 Google (US)
4.4 NVIDIA Corporation (US)
4.5 Atomwise, Inc. (US)
4.6 Exscientia (UK)
4.7 Cyclica (Canada)
4.8 BIOAGE (US)
4.9 Numerate (US)
4.10 Numedii (US)
4.11 Envisagenics (US)
4.12 twoXAR (US),
4.13 OWKIN, Inc. (US)
4.14 XtalPi (US)
4.15 Verge Genomics (US)
4.16 Berg LLC (US)
4.17 Deep Genomics (Canada)
4.18 Cloud Pharmaceuticals (US)
4.19 Insilico Medicine (US)
4.20 Benevolent AI (UK)
…
Buy Now: https://www.marketandreport.com/buy_now?artificial-intelligence-in-drug-discovery-market-2393
Contact Us:
Mike
Partner Relations & Marketing Manager
MarketandReport
400 Skokie Blvd, STE 200,
Northbrook, IL 60062, USA
Email: sales@marketandreport.com
Comments
Post a Comment